JFGIW
WST icon

Johnson Financial Group Inc (Wisconsin)’s West Pharmaceutical WST Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16
Closed -$4.01K – 954
2026
Q1 		$4.01K Sell
16
-5
-24% -$1.24K ﹤0.01% 716
2025
Q4 		$5.78K Sell
21
-58
-73% -$15.9K ﹤0.01% 697
2025
Q3 		$20.7K Buy
+79
New +$19.2K ﹤0.01% 709
2025
Q2 		– Sell
-138
Closed -$30.9K – 921
2025
Q1 		$30.9K Buy
138
+127
+1,155% +$35K ﹤0.01% 682
2024
Q4 		$3.76K Sell
11
-16
-59% -$5.04K ﹤0.01% 756
2024
Q3 		$8.11K Buy
+27
New +$8.27K ﹤0.01% 712
2019
Q1 		– Sell
-28
Closed -$3K – 554
2018
Q4 		$3K Hold
28
– – ﹤0.01% 491
2018
Q3 		$3K Hold
28
– – ﹤0.01% 507
2018
Q2 		$3K Buy
+28
New +$2.58K ﹤0.01% 512
2016
Q3 		– Sell
-500
Closed -$38K – 742
2016
Q2 		$38K Buy
500
+237
+90% +$17.2K 0.01% 474
2016
Q1 		$19K Sell
263
-295
-53% -$17.7K ﹤0.01% 520
2015
Q4 		$33K Sell
558
-2,392
-81% -$144K 0.01% 441
2015
Q3 		$160K Hold
2,950
– – 0.04% 280
2015
Q2 		$171K Sell
2,950
-975
-25% -$54.4K 0.04% 271
2015
Q1 		$236K Sell
3,925
-325
-8% -$17.3K 0.05% 243
2014
Q4 		$226K Sell
4,250
-350
-8% -$17.5K 0.05% 229
2014
Q3 		$206K Buy
4,600
+25
+0.5% +$1.06K 0.05% 217
2014
Q2 		$193K Buy
4,575
+3,100
+210% +$133K 0.05% 229
2014
Q1 		$65K Hold
1,475
– – 0.02% 329
2013
Q4 		$72K Sell
1,475
-1,150
-44% -$53.8K 0.02% 320
2013
Q3 		$108K Sell
2,625
-3,325
-56% -$127K 0.03% 290
2013
Q2 		$209K Buy
+5,950
New +$196K 0.06% 204

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s WST Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 16 shares — an estimated $4.01K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in WST in Q2 2013 and held it in 22 quarters. The position peaked at $236K in Q1 2015. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 16 West Pharmaceutical shares in Q2 2026, an estimated $4.01K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in West Pharmaceutical in Q2 2013 and held it in 22 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s West Pharmaceutical position peaked at $236K in Q1 2015.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.